The Autonomic Nervous System and Energy Metabolism

  • E. Westermann
  • K. Stock
Chapter

Summary

The mechanism by which fat stores are mobilized is of central importance to an understanding of energy metabolism in general. Apart from the fact that the dynamic state of adipose tissue can be regulated by the influx of glucose into the fat cell, a number of hormones are able to stimulate lipolysis as well as glycogenolysis by a direct interaction with a “Metabolic Receptor”.

In this context it is difficult to overestimate the importance of the work of Sutherland and coworkers who developed the concept that cyclic 3’, 5’-AMP is a “Second Messenger” in metabolic processes. This nucleotide, formed by adenyl cyclase in all nucleated cells, is the trigger through which a physiologic event — the release of a hormone — is translated to a metabolic event — lipolysis or glycogenolysis. Thus, it appears that the metabolic receptor is identical with the enzyme adenylcyclase which converts ATP to cyclic 3’, 5’-AMP. In this reaction catecholamines exert a catalytic function by interaction with the enzyme and substrate as well.

Our experiments with various stimulants and inhibitors of lipolysis indicate that the adenyl cyclase — ATP — complex in adipose tissue behaves like a sympathetic β-receptor. Although both, α- and β-adrenolytics, are able to block the action of noradrenaline and adrenaline, only β-adrenolytics produce this effect already in very low concentrations, stero-specifically and in a competitive manner. In addition, β-adrenolytics have a second point of attack in the lipolytic systems, which is probably located beyond the adenyl cyclase step and possibly identical with that of α-adrenolytics. This suggestion, however, remains speculative as long as nothing is known about the interconversion of inactive and active triglyceride lipase.

Keywords

Adipose Tissue Free Fatty Acid Autonomic Nervous System Adenyl Cyclase Plasma Free Fatty Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahlquist, R. P.: A study of the adrenotropic receptors. Amer. J. Physiol. 153, 586–600 (1948).PubMedGoogle Scholar
  2. Aulich, A., Stock, and E. Westermann: Lipolytic effects of cyclic adenosine-3’, 5’-monophosphate and its butyryl derivatives, and their inhibition by a-and (3adrenolytics. Life Sci. 6, 929–938 (1967).PubMedCrossRefGoogle Scholar
  3. Belleau, B.: Stericc effects in catecholamine interactions with enzymes and receptors. Pharmacol. Rev. Baltimore, 18, 131–140 (1966).Google Scholar
  4. Berthet, J.: Action du glucagon et de l’adrénaline sur le métabolisme des lipides dans le tissu hépatique. 4. Internat. Congr. Biochem. 17, 107 (1960).Google Scholar
  5. Bloom, B. M., and I. M. Goldman: The nature of catecholamine-adenine mono-nucleotide interactions in adrenergic mechanisms. Advances in Drug Res. Vol. 3, 121–169. London: Academic Press, 1966.Google Scholar
  6. Butcher, R. W.: Cyclic 3’, 5’-AMP and the lipolytic effects of hormones on adipose tissue. Pharmacol. Rev., Baltimore, 18, 237–241 (1966).Google Scholar
  7. Chytil, F., and J. Skrivanova: Reactivation of cortisone-induced liver tryptophan pyrrolase by boiled liver cell sap and by cyclic adenosine-3’, 5’-phosphate. Biochim. Biophys. Acta 67, N. Y. 164–166 (1963).Google Scholar
  8. Furchgott, R. F.: The receptors for epinephrine and norepinephrine (adrenergic receptors). Pharmacol. Rev., Baltimore, 11, 429–441 (1959).Google Scholar
  9. Haynes, R. C., E. W. Sutherland and T. W. Rail: The role of cyclic adenylic acid in hormone action. Recent Progr. Hormone Res., N. Y., 16, 121–133 (1960)Google Scholar
  10. Hegnauer, A. H., and G. T. Cori: The influence of epinephrine on chemical changes in the isolated frog muscle. J. Biol. Chem., Baltimore, 105, 691–703 (1934).Google Scholar
  11. Hess, W. R.: Die funktionelle Organisation des Vegetativen Nervensystems. Basel. Benno Schwabe, 1948.Google Scholar
  12. Lesser, E. J.: Der Mechanismus der Zuckermobilisierung durch das Adrenalin. Biochem. Zschr. 102, 304–319 (1920).Google Scholar
  13. Mansour, T. E.: Studies on heart phosphofructokinase; active and inactive forms of the enzyme. J. Biol. Chem., Baltimore, 240, 2165–2172 (1965).Google Scholar
  14. Posternak, Th., E. W. Sutherland, and W. F. Henion: Derivatives of cyclic 3’, 5’-adenosine monophosphate. Biochim. Biophys. Acta, N. Y., 65, 558–560 (1962).Google Scholar
  15. Pryor, J., and J. Berthet: The action of adenosine-3’, 5’-monophosphate on the incorporation of leucine into liver proteins. Biochim. Biophys. Acta 43, 556–557 (1960).PubMedCrossRefGoogle Scholar
  16. Rizack, M. A.: Activation of an epinephrine-sensitive lipolytic activity from adipose tissue by adenosine-3’, 5’-monophosphate. J. Biol. Chem., Baltimore, 239, 392–395 (1964).Google Scholar
  17. Roseli-Perez, M., and J. Lamer: Studies on UDPG-a-glucan-transglucosylase. V. Two forms of the enzyme in dog skeletal muscle and their interconversion. Biochemistry 3, 81–88 (1964).CrossRefGoogle Scholar
  18. Stock, K., and E. Westermann: Effects of adrenergic blockade and nicotinic acid on the mobilization of free fatty acids. Life Sci. 4, 1115–1124 (1965 a).CrossRefGoogle Scholar
  19. Stock, K., and E. Westermann: Über die Bedeutung des Noradrenalingehalts im Fettgewebe für die Mobilisierung unveresterter Fettsäuren. Naunyn-Schmiedebergs Arch. exper. Path. 251, 465–487 (1965 b).Google Scholar
  20. Stock, K., and E. Westermann: Hemmung der Lipolyse durch a-und (l-Sympathicolytica, Nicotinsäure und Prostaglolyin Er. Naunyn-Schmiedebergs Arch. Pharmak. exper. Path. 254, 334–354 (1966).Google Scholar
  21. Stock, K., and E. Westermann: Competitive and noncompetitive inhibition of lipolysis by a-and (3-adrenergic blocking agents, methoxamine derivatives and prostaglandine El. Life Sci. 5, 1667–1678 (1966).CrossRefGoogle Scholar
  22. Sutherland, E. W., and C. F. Cori: Effect of hyperglycemic-glycogenolytic factors and epinephrine on liver phosphorylase. J. Biol. Chem., Baltimore, 188, 531–543 (1951).Google Scholar
  23. Sutherland, E. W., and T. W. Ball: Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles. J. Biol. Chem., Baltimore, 232, 1077–1091 (1958).Google Scholar
  24. Sutherland, E. W., and T. W. Rail: The relation of adenosine-3’, 5’-phosphate and phosphorylase to the actions of catecholamines and other hormones. Pharmacol. Rev., Baltimore, 12, 265–299 (1960).Google Scholar
  25. Sutherland, E. W., and G. A. Robison: The role of cyclic 3’, 5’-AMP in responses to catecholamines and other hormones. Pharmacol. Rev., Baltimore, 18, 145–161 (1966).Google Scholar
  26. Sutherland, E. W., I. Oye, and R. W. Butcher: The action of epinephrine and the role of the adenyl cyclase system in hormone action. Rec. Progr. Horm. Res. 21, 623–646 (1965).PubMedGoogle Scholar
  27. Westermann, E.: Drugs affecting the mobilization of free fatty acids. Pathophysiological and clinical aspects of lipid metabolism, pp. 38–48. Stuttgart: Georg Thieme 1966.Google Scholar
  28. Westermann, E.: Sympathicus und Fettstoffwechsel. Acta neuroveget, Wien, 30, 19–29 (1967).Google Scholar
  29. Westermann, E.: Mechanismus und pharmakologische Beeinflussung der endokrinen Lipolyse. 12. Symp. Dtsch. Ges. Endokrinologie, pp. 154–173. Heidelberg/ New York: Springer, 1967b.Google Scholar
  30. Westermann, E., K. Stock, and P. Bieck: False transmitter substances in mammalian adipose tissue. Progr. biochem. Pharmacol. 3, 233–247 (1967).Google Scholar

Copyright information

© Springer-Verlag Wien 1969

Authors and Affiliations

  • E. Westermann
    • 1
  • K. Stock
    • 1
  1. 1.Department of PharmacologyMedical School of HannoverHannover-KleefeldGermany

Personalised recommendations